Cogent Biosciences, Inc. COGT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s net change in cash?
- Cogent Biosciences, Inc. (COGT) reported net change in cash of -$70.8M in Q1 2026.
- How has Cogent Biosciences, Inc.'s net change in cash changed year-over-year?
- Cogent Biosciences, Inc.'s net change in cash decreased by 354.3% year-over-year, from $27.84M to -$70.8M.
- What is the long-term trend for Cogent Biosciences, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Cogent Biosciences, Inc.'s net change in cash has grown at a 64.6% compound annual growth rate (CAGR), from -$79.8M to $216.23M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.